搜尋結果
Alnylam Pharma Shares Surge 30% After Rare Heart Disease Drug Succeeds
Forbes· 11 小時前Shares of Alnylam Pharmaceuticals rose by over 32%, the company’s largest single-day gain in ...
With Robust AI Prospects Is IBM A Better Pick Over Merck Stock Within The Dow Index?
Forbes· 11 小時前Although Merck has seen a better revenue growth, IBM is more profitable. There is more to the ...
Is Nvidia Enthusiasm Wearing Off?
Forbes· 11 小時前Stocks ended last week with a whimper, but both the S&P 500 and Nasdaq Composite managed to ...
Softbank’s GenAI CSR App And May’s Confusing Retail Results, Explained
Forbes· 11 小時前This week in retail: Softbank pre-announces a controversial GenAI app for call centers, while NRF and US Census released ...
Council Post: Why Nonprofits Need To Think More Like Marketers With Their Strategic Plans
Forbes· 11 小時前As someone with a background mostly rooted in marketing, I might be biased, but I firmly ...
Council Post: A Paradigm Shift For Healthtech CEOs: Increasing Patient Satisfaction And Retention
Forbes· 11 小時前In our hyperconnected world, seamless communication is the norm. Having witnessed the ...
How Does The Current Fall In Diageo Stock Compare With That During The 2008 Recession?
Forbes· 11 小時前In contrast, its peer Anheuser-Busch InBev stock (NYSE: BUD) saw a 2% decline over this period. ...
Will Roche Stock Rebound To Its 2022 Highs Of $50?
Forbes· 11 小時前In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% decline over this ...
As Streaming Business Approaches Profitability, Can Disney Stock Double To $200?
Forbes· 11 小時前Disney stock currently trades at $102 per share, about 50% below its pre-inflation shock high ...
Billionaire Charoen To Open Nobu Restaurant Atop Bangkok Skyscraper
Forbes· 11 小時前Billionaire Charoen Sirivadhanabhakdi’s Asset World plans to open a Nobu restaurant on the roof deck of its Empire mixed-used ...